Clinical Trial Update: Glycine and D-Cycloserine in Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating glycine and D-cycloserine for schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• D-cycloserine (D-cycloserine)
• Glycine (glycine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 3 | Status: WITHDRAWN